Morgan Stanley Issues Pessimistic Forecast for Bath & Body Works (NYSE:BBWI) Stock Price

Bath & Body Works logo with Consumer Discretionary background
Image from MarketBeat Media, LLC.

Key Points

  • Morgan Stanley cut its Bath & Body Works price target from $22 to $21 and maintained an “equal weight” rating; the new target implies 10.91% upside from the prior close.
  • Analyst sentiment is broadly cautious: the stock has an average “Hold” rating and a $22.40 consensus price target.
  • Although quarterly earnings and revenue topped estimates, revenue fell 1.1% year over year. The company’s fourth-quarter EPS guidance of $1.41–$1.61 is below analyst expectations, amid warnings of softer holiday sales.
  • Five stocks to consider instead of Bath & Body Works.

Bath & Body Works (NYSE:BBWI - Get Free Report) had its price target reduced by investment analysts at Morgan Stanley from $22.00 to $21.00 in a report released on Friday, Benzinga reports. The firm presently has an "equal weight" rating on the stock. Morgan Stanley's target price would suggest a potential upside of 10.91% from the stock's previous close.

Other equities analysts have also issued research reports about the company. BMO Capital Markets began coverage on Bath & Body Works in a research note on Tuesday, September 8th. They issued a "market perform" rating and a $20.00 target price on the stock. Citigroup raised Bath & Body Works from a "neutral" rating to a "buy" rating and set a $25.00 price target for the company in a research note on Tuesday, August 18th. Deutsche Bank set a $22.00 price target on shares of Bath & Body Works in a research report on Thursday, August 27th. Weiss Ratings reiterated a "hold (c-)" rating on shares of Bath & Body Works in a research report on Tuesday, October 6th. Finally, Jefferies Financial Group reissued a "hold" rating and set a $21.00 price objective on shares of Bath & Body Works in a research note on Thursday. Three research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus price target of $22.40.

Read Our Latest Stock Analysis on Bath & Body Works

Bath & Body Works Stock Performance

Shares of Bath & Body Works stock opened at $18.93 on Friday. The firm has a fifty day moving average of $19.24 and a two-hundred day moving average of $19.77. The stock has a market capitalization of $3.82 billion, a price-to-earnings ratio of 4.93, a PEG ratio of 0.93 and a beta of 1.31. Bath & Body Works has a 52 week low of $14.27 and a 52 week high of $24.94.

Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its quarterly earnings results on Thursday, November 19th. The company reported $0.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.12 by $0.14. Bath & Body Works had a negative return on equity of 53.48% and a net margin of 10.83%. The business had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.55 billion. During the same period last year, the company earned $0.37 EPS. The firm's revenue was down 1.1% on a year-over-year basis. Bath & Body Works has set its Q4 2026 guidance at 1.410-1.610 EPS and its FY 2026 guidance at 2.600-2.800 EPS. As a group, research analysts forecast that Bath & Body Works will post 2.74 EPS for the current fiscal year.

Institutional Investors Weigh In On Bath & Body Works

Large investors have recently modified their holdings of the business. Algert Global LLC grew its position in shares of Bath & Body Works by 36.0% in the 3rd quarter. Algert Global LLC now owns 684,287 shares of the company's stock valued at $10,894,000 after purchasing an additional 181,023 shares during the period. Ancora Advisors LLC lifted its stake in Bath & Body Works by 107,891.7% in the third quarter. Ancora Advisors LLC now owns 12,959 shares of the company's stock valued at $206,000 after buying an additional 12,947 shares in the last quarter. Readystate Asset Management LP lifted its stake in Bath & Body Works by 408.8% in the third quarter. Readystate Asset Management LP now owns 579,712 shares of the company's stock valued at $9,229,000 after buying an additional 465,780 shares in the last quarter. Ares Systematic Credit Ltd acquired a new position in shares of Bath & Body Works in the third quarter valued at approximately $442,000. Finally, Saba Capital Management L.P. increased its position in shares of Bath & Body Works by 784.2% during the third quarter. Saba Capital Management L.P. now owns 84,111 shares of the company's stock worth $1,339,000 after acquiring an additional 74,598 shares in the last quarter. 95.14% of the stock is currently owned by institutional investors.

Key Headlines Impacting Bath & Body Works

These are some of the BBWI headlines that stood out recently:

  • Positive Sentiment: A new $500 million share-repurchase authorization may support shareholder returns. Management also cited progress in digital and wholesale sales, while its Fuel for Growth program is expected to generate $200 million in cost savings. Long-term investor takeaways
  • Neutral Sentiment: A limited-edition holiday fragrance collection with Pantone adds a new gifting and home-products offering, though its sales impact is not yet clear. Pantone holiday collection
  • Negative Sentiment: Investors face a weaker near-term outlook: fourth-quarter EPS guidance of $1.41–$1.61 is below the $1.72 analyst consensus, and the company warned of softer holiday sales. Third-quarter revenue was down about 1% year over year, and EPS was below the year-ago level. Holiday sales outlook

About Bath & Body Works

(Get Free Report)

Bath & Body Works, Inc. is a specialty retailer focused on personal care and home fragrance products. Its offerings include body lotions, soaps, fragrances, hand sanitizers, candles and other home-fragrance items, sold under the Bath & Body Works and White Barn brands. The company serves customers through its stores and e-commerce platform in the United States and Canada, as well as through international franchise, license and wholesale partners. Bath & Body Works traces its roots to a store launched in 1990.

Recommended Stories

Analyst Recommendations for Bath & Body Works (NYSE:BBWI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Bath & Body Works Right Now?

Before you consider Bath & Body Works, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.

While Bath & Body Works currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines